Recep Tayyip Erdoğan University Institutional Repositorymetadata only
Methylprednisolone in the management of post-COVID-19 interstitial lung disease: A randomized trial (STERCOV-ILD)
covid-19, hypoxemia, interstitial lung disease, methylprednisolone, vital capacity
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 351958
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.